Somatostatin analog therapy for severe polycystic liver disease: results after 2 years

Author： Hogan Marie C.   Page Linda   Holmes David R.   Li Xujian   Bergstralh Eric J.   Irazabal Maria V.   Kim Bohyun   King Bernard F.   Glockner James F.   LaRusso Nicholas F.   Torres Vicente E.  

Publisher： Oxford University Press

ISSN： 1460-2385

Source： Nephrology Dialysis Transplantation, Vol.27, Iss.9, 2012-09, pp. : 3532-3539

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Somatostatin analog therapy in treatment of gastrointestinal disorders and tumors

By Herder Wouter   Lamberts Steven  

Endocrine Journal, Vol. 20, Iss. 3, 2003-04 ,pp. : 285-290

Humana Press, Inc

Access to resources Recommend Favorite

Optimizing Somatostatin Analog Therapy in Acromegaly: Long-Acting Formulations

By Gilroy J.J.  

Treatments in Endocrinology, Vol. 1, Iss. 3, 2002-03 ,pp. : 149-154

Adis International

Access to resources Recommend Favorite

Monoethanolamine Oleate Sclerotherapy for Polycystic Liver Disease

By  

Digestive Diseases, Vol. 34, Iss. 6, 2016-10 ,pp. : 654-658

Karger

Access to resources Recommend Favorite

Gene Therapy for Liver Disease

By  

Digestive Diseases, Vol. 16, Iss. 1, 1998-02 ,pp. : 23-37

Karger

Access to resources Recommend Favorite

Polycystic ovary syndrome: A follow-up study on diabetes mellitus, cardiovascular disease and malignancy 15-25 years after ovarian wedge resection

By Lunde Ottar   Tanbo Tom  

Gynecological Endocrinology, Vol. 23, Iss. 12, 2007-12 ,pp. : 704-709

Informa Healthcare

Access to resources Recommend Favorite